Show simple item record

dc.contributor.authorUzbeck, Mateen H
dc.contributor.authorAlmeida, Francisco A
dc.contributor.authorSarkiss, Mona G
dc.contributor.authorMorice, Rodolfo C
dc.contributor.authorJimenez, Carlos A
dc.contributor.authorEapen, Georgie A
dc.contributor.authorKennedy, Marcus P
dc.date.accessioned2012-01-05T12:54:24Z
dc.date.available2012-01-05T12:54:24Z
dc.date.issued2010-06
dc.identifier.citationManagement of malignant pleural effusions. 2010, 27 (6):334-47 Adv Theren
dc.identifier.issn1865-8652
dc.identifier.pmid20544327
dc.identifier.doi10.1007/S12325-010-0031-8
dc.identifier.urihttp://hdl.handle.net/10147/200291
dc.descriptionMalignant pleural effusions are a common clinical problem in patients with primary thoracic malignancy and metastatic malignancy to the thorax. Symptoms can be debilitating and can impair tolerance of anticancer therapy. This article presents a comprehensive review of pharmaceutical and nonpharmaceutical approaches to the management of malignant pleural effusion, and a novel algorithm for management based on patients' performance status.en
dc.description.abstractMalignant pleural effusions are a common clinical problem in patients with primary thoracic malignancy and metastatic malignancy to the thorax. Symptoms can be debilitating and can impair tolerance of anticancer therapy. This article presents a comprehensive review of pharmaceutical and nonpharmaceutical approaches to the management of malignant pleural effusion, and a novel algorithm for management based on patients' performance status.
dc.language.isoenen
dc.subject.meshAlgorithms
dc.subject.meshAnastomosis, Surgical
dc.subject.meshCatheters, Indwelling
dc.subject.meshChest Tubes
dc.subject.meshCost-Benefit Analysis
dc.subject.meshDecision Support Techniques
dc.subject.meshDecision Trees
dc.subject.meshDrainage
dc.subject.meshHumans
dc.subject.meshPalliative Care
dc.subject.meshParacentesis
dc.subject.meshPatient Selection
dc.subject.meshPleural Effusion, Malignant
dc.subject.meshPleurodesis
dc.subject.meshSclerosing Solutions
dc.subject.meshThoracoscopy
dc.subject.meshThoracostomy
dc.subject.meshTreatment Outcome
dc.titleManagement of malignant pleural effusions.en
dc.typeArticleen
dc.contributor.departmentDepartment of Pulmonary Medicine, MD Anderson Cancer Center, Houston, Texas, USA.en
dc.identifier.journalAdvances in therapyen
dc.description.provinceMunster
html.description.abstractMalignant pleural effusions are a common clinical problem in patients with primary thoracic malignancy and metastatic malignancy to the thorax. Symptoms can be debilitating and can impair tolerance of anticancer therapy. This article presents a comprehensive review of pharmaceutical and nonpharmaceutical approaches to the management of malignant pleural effusion, and a novel algorithm for management based on patients' performance status.


This item appears in the following Collection(s)

Show simple item record